Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,168.80
(
-0.14%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.20
(
4.63%
)
Bitcoin
78,157.16
(
-0.10%
)
News Focus
News Focus
Post# of 517546
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ExtremelyBullishZig

Send PM Follow Ignore
Followers 43
Posts 10953
Boards Moderated 0
Alias Born 05/12/2006

ExtremelyBullishZig

Re: investor300 post# 99062

Sunday, 04/02/2017 7:23:15 PM

Sunday, April 02, 2017 7:23:15 PM

Post# of 517546
Read this one again...then read it again...and again...and keep reading until you get it:

Phase2a ***updates*** on 104 Extension Alzheimer's study.

That means updates on progress. We expected it because the company spread published an abstract that stated 15-month data and submitted it to the conference.

Since that hasn't happened yet, expect extension trial updates before PK data.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News